Does OLAPARIB Cause Decreased activity? 30 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 30 reports of Decreased activity have been filed in association with OLAPARIB (Lynparza). This represents 0.2% of all adverse event reports for OLAPARIB.
30
Reports of Decreased activity with OLAPARIB
0.2%
of all OLAPARIB reports
0
Deaths
4
Hospitalizations
How Dangerous Is Decreased activity From OLAPARIB?
Of the 30 reports, 4 (13.3%) required hospitalization.
Is Decreased activity Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OLAPARIB. However, 30 reports have been filed with the FAERS database.
What Other Side Effects Does OLAPARIB Cause?
Death (4,378)
Malignant neoplasm progression (1,862)
Nausea (1,582)
Anaemia (1,455)
Fatigue (1,437)
Off label use (777)
Vomiting (642)
Drug ineffective (563)
Diarrhoea (514)
Asthenia (491)
What Other Drugs Cause Decreased activity?
NIRAPARIB (586)
SACUBITRIL\VALSARTAN (570)
RUXOLITINIB (558)
DUPILUMAB (231)
LEVOTHYROXINE (201)
TREPROSTINIL (195)
PREDNISONE (193)
ALBUTEROL (190)
EMTRICITABINE\TENOFOVIR DISOPROXIL (186)
TERIPARATIDE (156)
Which OLAPARIB Alternatives Have Lower Decreased activity Risk?
OLAPARIB vs OLARATUMAB
OLAPARIB vs OLECLUMAB
OLAPARIB vs OLIVE OIL\SOYBEAN OIL
OLAPARIB vs OLMESARTAN
OLAPARIB vs OLMESARTAN MEDOXOMIL